Alane P Barnes, the Chief Legal Officer of $BCRX, sold 19,770 shares of the company on 12-03-2025 for an estimated $151,240. We received data on the trade from a recent SEC filing. This was a sale of approximately 5.4% of their shares of this class of stock. Following this trade, they now own 345,476 shares of this class of $BCRX stock.
$BCRX Insider Trading Activity
$BCRX insiders have traded $BCRX stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $BCRX stock by insiders over the last 6 months:
- ALANE P BARNES (Chief Legal Officer) has made 0 purchases and 3 sales selling 161,680 shares for an estimated $1,164,966.
- THERESA HEGGIE sold 70,000 shares for an estimated $595,868
- MACHELLE SANDERS sold 9,600 shares for an estimated $68,544
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BCRX Hedge Fund Activity
We have seen 133 institutional investors add shares of $BCRX stock to their portfolio, and 168 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DEERFIELD MANAGEMENT COMPANY, L.P. added 7,477,000 shares (+159.4%) to their portfolio in Q3 2025, for an estimated $56,750,430
- AVORO CAPITAL ADVISORS LLC removed 3,250,000 shares (-72.2%) from their portfolio in Q3 2025, for an estimated $24,667,500
- D. E. SHAW & CO., INC. removed 2,680,141 shares (-61.1%) from their portfolio in Q3 2025, for an estimated $20,342,270
- HOOD RIVER CAPITAL MANAGEMENT LLC added 2,376,327 shares (+191.0%) to their portfolio in Q3 2025, for an estimated $18,036,321
- WALLEYE CAPITAL LLC removed 2,073,564 shares (-90.1%) from their portfolio in Q3 2025, for an estimated $15,738,350
- JANE STREET GROUP, LLC added 1,569,848 shares (+563.7%) to their portfolio in Q3 2025, for an estimated $11,915,146
- VOLORIDGE INVESTMENT MANAGEMENT, LLC removed 1,517,054 shares (-61.3%) from their portfolio in Q3 2025, for an estimated $11,514,439
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BCRX Revenue
$BCRX had revenues of $159.4M in Q3 2025. This is an increase of 36.14% from the same period in the prior year.
You can track BCRX financials on Quiver Quantitative's BCRX stock page.
$BCRX Analyst Ratings
Wall Street analysts have issued reports on $BCRX in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citizens issued a "Market Outperform" rating on 11/05/2025
- Needham issued a "Buy" rating on 11/04/2025
- TD Cowen issued a "Buy" rating on 10/15/2025
- Cantor Fitzgerald issued a "Overweight" rating on 10/15/2025
- B of A Securities issued a "Buy" rating on 07/01/2025
- RBC Capital issued a "Outperform" rating on 06/30/2025
- Wedbush issued a "Outperform" rating on 06/30/2025
To track analyst ratings and price targets for $BCRX, check out Quiver Quantitative's $BCRX forecast page.
$BCRX Price Targets
Multiple analysts have issued price targets for $BCRX recently. We have seen 9 analysts offer price targets for $BCRX in the last 6 months, with a median target of $18.0.
Here are some recent targets:
- Jonathan Wolleben from Citizens set a target price of $25.0 on 11/05/2025
- Serge Belanger from Needham set a target price of $18.0 on 11/04/2025
- Gena Wang from Barclays set a target price of $9.0 on 11/04/2025
- Stacy Ku from TD Cowen set a target price of $30.0 on 10/15/2025
- Steven Seedhouse from Cantor Fitzgerald set a target price of $26.0 on 10/15/2025
- Jonathan Wolleben from JMP Securities set a target price of $27.0 on 10/15/2025
- Tazeen Ahmad from B of A Securities set a target price of $15.0 on 07/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
